N. Amos
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 5
- Immunology top 10%
- Complement system in diseases 6
- Hematology top 10%
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 4
- Systemic Lupus Erythematosus Research 3
- Immunology and Allergy top 10%
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Erythrocyte Function and Pathophysiology 4
-
- Glycosylation and Glycoproteins Research 3
- RNA Interference and Gene Delivery 3
- Co-authors
- D K PetersJ. G. P. SissonsBryan WilliamsAnwen S. WilliamsWilliam G. LoveRichard WestBarbara J. BoucherI.W. Kellaway
- Cited by
- NephrologyImmunologyHematology
- Journals
- Lara D. Veeken (3 papers)Inflammation Research (2 papers)Journal of Pharmacy and Pharmacology (2 papers)
- Partner nations
- United KingdomIsraelUnited States
In The Last Decade
N. Amos
34 papers receiving 836 citations
Peers
Comparison fields: 5 of 83
- Nephrology 182
- Immunology 338
- Hematology 147
- Rheumatology 181
- Immunology and Allergy 60
Countries citing papers authored by N. Amos
This map shows the geographic impact of N. Amos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Amos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Amos more than expected).
Fields of papers citing papers by N. Amos
This network shows the impact of papers produced by N. Amos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Amos. The network helps show where N. Amos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N. Amos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2006 | 64 | |
| 4 | 2002 | 82 | |
| 5 | 2000 | 36 | |
| 6 | 1999 | 23 | |
| 7 | 1999 | 18 | |
| 8 | 1995 | 6 | |
| 9 | 1995 | 30 | |
| 10 | 1995 | 15 | |
| 11 | 1995 | 20 | |
| 12 | Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions. | 1991 | 24 |
| 13 | 1990 | 16 | |
| 14 | 1989 | 21 | |
| 15 | 1987 | 26 | |
| 16 | 1985 | 27 | |
| 17 | 1984 | 6 | |
| 18 | Guinea-pig nephrotoxic nephritis II. Autologous phase: complement activation without detectable injury. | 1977 | 4 |
| 19 | 1976 | 201 | |
| 20 | Guinea-pig nephrotoxic nephritis. I. The role of complement and polymorphonuclear leucocytes and the effect of antibody subclass and fragments in the heterologous phase. | 1975 | 25 |
About N. Amos
N. Amos is a scholar working on Nephrology, Hematology, Immunology, Immunology and Allergy and Rheumatology, having authored 35 papers that have together received 917 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (5 papers), Erythrocyte Function and Pathophysiology (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Glycosylation and Glycoproteins Research (3 papers), RNA Interference and Gene Delivery (3 papers) and Systemic Lupus Erythematosus Research (3 papers). The work is most often cited by research in Nephrology (182 citations), Immunology (338 citations), Hematology (147 citations), Rheumatology (181 citations) and Immunology and Allergy (60 citations). N. Amos has collaborated with scholars based in United Kingdom, Israel and United States. Frequent co-authors include D K Peters, J. G. P. Sissons, Bryan Williams, Anwen S. Williams, William G. Love, Richard West, Barbara J. Boucher, I.W. Kellaway, J. Camilleri and P. J. Lachmann. Their work appears in journals such as Lara D. Veeken, Inflammation Research, Journal of Pharmacy and Pharmacology, Annals of the Rheumatic Diseases and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.